BGMS - מזומני החברה cyclacel.com

Bio Green Med Solution Inc is attracting experts through RSU shares while advancing cellular research. The volume of physical cash demonstrates current liquidity, where 0.00 represents the latest level value. Molecule patents ensure global growth and high margins, while the operational eco-footprint remains minimal and limited to standard chemical disposal.
פילוחי נתונים אנליטיים מרוכזים עבור Bio Green Med Solution Inc. (BGMS)

This metric captures the total volume of liquid assets in the issuer's accounts at the close of trading sessions, determining the company's ability to instantaneously meet short-term obligations. An analysis of current cash reserves allows for an assessment of the financial cushion of Bio Green Med Solution Inc. (BGMS) to fund the development of targeted oncology drugs and the diversification of a drug portfolio focused on DNA repair and cell cycle control.